HB1292
Interim Study (House)expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.
House
Judiciary
2026 Session
Status
Introduced
House Committee
House Vote
Senate
Senate Vote
Governor
Interim Study (House)
Hearing
- Date
- September 30, 2026
- Time
- 10:00 AM
- Committee
- House Judiciary
- Location
- GP Room 230
Testimony
Support
145
Oppose
8
153 total submissions
Bill Docket
Executive Session: 09/30/2026 10:00 am GP 230
HouseSeptember 04, 2026
Refer for Interim Study: MA VV 03/05/2026 HJ 6 P. 24
HouseMarch 05, 2026
Committee Report: Refer for Interim Study 02/13/2026 (Vote 17-1; CC) HC 9 P. 18
HouseFebruary 26, 2026
Executive Session: 02/13/2026 10:00 am GP 158
HouseFebruary 05, 2026
Public Hearing: 02/11/2026 01:00 pm GP 230
HouseFebruary 05, 2026
Introduced 01/07/2026 and referred to Judiciary HJ 1 P. 14
HouseDecember 01, 2025
Bill Text (Introduced)
Loading bill text...